SEP 4, 2026 · PHASE 3 TRIAL
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ClinicalTrials.gov
This is a Phase 3 registry record with no reported results; the study is actively recruiting and designed to test a combination approach in a dual-disease population, but outcomes remain unreported.
Reported
Planned enrollment290
PhasePhase 3
Primary outcome measurePercentage of Participants Who Simultaneous…